These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 19602990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E.
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [Abstract] [Full Text] [Related]

  • 6. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R, Thomas JL.
    Praxis (Bern 1994); 1997 Aug 13; 86(33):1245-8. PubMed ID: 9381009
    [Abstract] [Full Text] [Related]

  • 7. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
    Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marrè GB.
    Arzneimittelforschung; 2006 Aug 13; 56(3):230-8. PubMed ID: 16618016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar 13; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 11. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA.
    Semin Reprod Med; 2005 May 13; 23(2):126-40. PubMed ID: 15852198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I, Alexander JL.
    J Sex Med; 2005 Sep 13; 2 Suppl 3():154-65. PubMed ID: 16422792
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
    Archer DF.
    J Steroid Biochem Mol Biol; 2015 Jan 13; 145():139-43. PubMed ID: 25201455
    [Abstract] [Full Text] [Related]

  • 17. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.
    Santos I, Clissold S.
    Gynecol Endocrinol; 2010 Sep 13; 26(9):644-51. PubMed ID: 20374067
    [Abstract] [Full Text] [Related]

  • 18. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
    Panay N, Maamari R.
    Menopause Int; 2012 Mar 13; 18(1):15-9. PubMed ID: 22393176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urogenital atrophy.
    Calleja-Agius J, Brincat MP.
    Climacteric; 2009 Aug 13; 12(4):279-85. PubMed ID: 19387880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.